Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

26.0K
Overview
26.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

267
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
267
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

274
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
274
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of the COVID-19 Pandemic on Outpatient Visit-Based Frequency Trends of Herpes Zoster Ophthalmicus.

Cureus·2026
Same author

Efficacy of Topical Epinastine Eyelid Cream for Perennial Allergic Conjunctivitis: A Prospective Study.

Cureus·2025
Same author

A case of immune checkpoint inhibitor-related conjunctivitis controlled by tacrolimus eye drops.

American journal of ophthalmology case reports·2025
Same author

Questionnaire survey among ophthalmic allergists on dupilumab-associated ocular surface disease in Japan.

Allergology international : official journal of the Japanese Society of Allergology·2024
Same author

Minimal Clinically Important Differences With the Outcomes of the App-Based Japanese Allergic Conjunctival Diseases Quality of Life Questionnaire: Cross-Sectional Observational Study.

JMIR formative research·2024
Same author

Use of explainable AI on slit-lamp images of anterior surface of eyes to diagnose allergic conjunctival diseases.

Allergology international : official journal of the Japanese Society of Allergology·2024

Related Experiment Video

Updated: Apr 22, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.5K

Oral immunotherapy for allergic conjunctivitis.

Waka Ishida1, Ken Fukuda, Yosuke Harada

  • 1*Department of Ophthalmology, Kochi Medical School, Kochi, Japan; and †Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.

Cornea
|October 8, 2014
PubMed
Summary
This summary is machine-generated.

Oral tolerance, induced by feeding allergens, effectively treats experimental allergic conjunctivitis. Genetically modified rice containing key Japanese cedar pollen antigens shows promise for developing new oral tolerance therapies.

More Related Videos

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

14.1K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.3K

Related Experiment Videos

Last Updated: Apr 22, 2026

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

2.5K
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

14.1K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.3K

Area of Science:

  • Immunology
  • Allergology
  • Biotechnology

Background:

  • Antigen-specific immunotherapy (ASIT) is a promising treatment for allergic diseases.
  • Current ASIT methods include subcutaneous and sublingual administration, inducing long-term remission.
  • Oral tolerance, induced via the oral route, is effective for various allergic conditions but less studied in allergic conjunctivitis.

Purpose of the Study:

  • To investigate the efficacy of oral tolerance in treating experimental allergic conjunctivitis.
  • To explore the potential of transgenic rice as a novel delivery system for oral tolerance induction.

Main Methods:

  • Previous studies demonstrated ovalbumin feeding suppressed ovalbumin-induced experimental allergic conjunctivitis.
  • Development of transgenic rice expressing modified Japanese cedar pollen antigens (Cryptomeria japonica 1 and 2).
  • Molecular engineering of antigens included shuffling, fragmentation, and altered oligomeric structure.

Main Results:

  • Oral administration of antigens can induce long-term remission, a phenomenon known as oral tolerance.
  • Ovalbumin feeding was previously shown to be effective in suppressing experimental allergic conjunctivitis.
  • Transgenic rice has been engineered to induce oral tolerance and reduce anaphylaxis severity.

Conclusions:

  • Oral tolerance is an effective strategy for managing experimental allergic conjunctivitis.
  • Transgenic rice engineered with modified Japanese cedar pollen antigens represents a potential new therapeutic approach for allergic conjunctivitis.